Type 2 Diabetes Treatments and Major Adverse Cardiovascular Events by Age and Sex, Simvastatin with Rifaximin for Decompensated Liver Cirrhosis, Approved vs Off-label Doxepin Formulation Trends and mo
by
JAMA Editors' Summary
2025-02-07 16:05:00
Release date
09:51
Length